We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis.
- Authors
Chen, Jeff W; Rogers, Shana L; Gombart, Zoe J; Adler, David E; Cecil, Sandy
- Abstract
Cerebral microdialysis (MD) provides valuable information about brain metabolism under normal and pathologic conditions. The CMA 600 microdialysis analyzer received US Food and Drug Administration (FDA) approval for clinical use in the United States in 2005. Since then, cerebral MD has been increasingly utilized nationally in the multimodal monitoring of traumatic brain injury (TBI), stroke, aneurysmal subarachnoid hemorrhage, and brain tumors. We describe a 5-year, single-institutional experience using cerebral MD at a community-based hospital, Legacy Emanuel Medical Center (LEMC). Implications for the adoption and utility of MD in medical centers with limited resources are discussed.
- Publication
Surgical neurology international, 2012, Vol 3, p57
- ISSN
2152-7806
- Publication type
Journal Article
- DOI
10.4103/2152-7806.96868